In Vitro
Lipid-based transfection reagents and electroporation systems are widely utilized, conventional methods to deliver siRNA and other conventional oligonucleotides into the cells. However, in many primary cells, particularly immune cells, hematopoietic cells and neurons, lipid reagents and electroporation are associated with high toxicity and poor transfection efficiency. Alternative delivery methods, such as viral vectors, require laborious optimization and viral production steps, and carry associated risk of genome integration.
AUMsilence ASOs have unique, state-of-the-art chemical modifications that allow for highly efficient cell delivery in the absence of transfection reagents, thus eliminating cell toxicity associated with lipid transfection reagents and electroporation. AUMsilence oligos have effective delivery and superior performance and work in a wide range of mammalian cell types, conventional cell lines, difficult-totransfect primary cells (B-cells, T-cells, neurons, etc.), as well as in vivo study models.
AUMsilence oligo Treatment Workflow